Skip Ribbon Commands
Skip to main content

Research & Publications


Our promise can be achieved, with your help.​

We are on a mission to create solutions, prevent and treat myopia in order to stem the rising tide of a global epidemic.

Your participation in our clinical studies will enable us to gather results through safe and non-intrusive methods to better understand myopia. Together, our goal of being one step closer to better vision can be within reach.

Keen to play a part? Speak to any of our friendly optometrists today to get started.

What is research?

Research is the systematic investigation into, and study of, a subject. At Myopia Centre, research is done to obtain more evidence for various myopia treatment options as well as improve our understanding of the myopic eye.


Why is research important?

Research plays an integral role in modern medicine. It is critical in developing new treatment options and increasing our knowledge.


Is research safe?

Contrary to common misconceptions that research participants are 'guinea pigs', there are now many guidelines in place that ensure the safety and health of research participants. These guidelines ensure the credibility and accuracy of the data and reported results and that the rights, integrity and confidentiality of the research participants are respected and protected.


Cohort Studies

Adult Cohort Study, PROMYSE

We are conducting a prospective cohort study of myopes aged 16 and above. We aim to identify factors associated with myopia progression and sight-threatening complications related to myopia. We are also interested in evaluating the impact of myopia and its complications on vision related quality of life. Participants will undergo a comprehensive eye examination – including pupil dilation- to ascertain eye degrees and health, as well as complete a short questionnaire on their vision and how it affects their life.


Children Cohort Study, PROM-Kids

As the options of myopia treatment increases, the main aim of this study is to monitor the myopia progression of children and their treatment modalities. We hope to definitively develop and refine a myopia treatment protocol, based on evidence. We will also be assessing changes of the eye to determine if these factors could be used to predict myopia progression or response to treatment. This study will be recruiting children and teenagers between the ages of four and 21. Participants will undergo a comprehensive eye examination to determine their eye degrees and health of their eyes.

ATOM 3 Clinical Trial: Join Us In Developing Early Treatment For Myopia

If your family has a history of myopia, did you know that your child is twice or thrice more likely to have it too? If your child develops myopia early, it more likely evolve to high myopia. Persons with high myopia are at greater risk of developing myopia complications such as early cataract, retinal degeneration/detachment and glaucoma later on in life.   

We are looking for clinical trial volunteers to help us see if a particular type of eye drops can prevent the onset of myopia or control its progression, and thereby prevent high myopia.

A child who meets the following criteria is eligible for this clinical trial:

  • Your child is between 5 to 9 years old
  • Either not yet wearing glasses OR has low myopia (less than -1.5D)
  • Has family history of myopia (one parent with myopia more than -3.00D)
  • Not currently receiving or had previously treatment (e.g. eye drops) for the treatment of myopia

If you are interested for your child to take part and wish to find out more, please contact +65 6322 4500 / +65 6322 4501 (Mondays- Fridays, 9am to 5 pm).

You may also leave your name and contact details via our phone answering service; or through our email address at

I am interested in ATOM3 Clinical Trial


30 Years of  Myopia Research

Myopia research has been an important point of focus at SERI even before its establishment in 1997. This publication is a summary that highlights 30 years of myopia research at SERI.